Ultragenyx Pharmaceutical... (RARE)
Ultragenyx Pharmaceutical Max Pain By Strike
RARE trades at $31.21, 4.0% above the near-term max pain of $30 expiring Oct 17, 2025 (11 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($15-$35), reflecting growing call interest at higher strikes. Key magnetic zone at 28 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Ultragenyx Pharmaceutical Max Pain By Expiry
Max pain for RARE shows an upward trend from 15 to 35, suggesting bullish positioning in longer-dated options. The 76% spread signals divergent expectations across timeframes. Most levels below 31.21 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
Expiration Date | Max Pain | Max Pain vs Current Price |
---|---|---|
Oct 17, 2025 | 30 | n/a (n/a) |
Nov 21, 2025 | 27.5 | n/a (n/a) |
Dec 19, 2025 | 35 | n/a (n/a) |
Jan 16, 2026 | 30 | n/a (n/a) |
Feb 20, 2026 | 27.5 | n/a (n/a) |
May 15, 2026 | 25 | n/a (n/a) |
Jan 15, 2027 | 20 | n/a (n/a) |
Jan 21, 2028 | 15 | n/a (n/a) |